The efficacy of aspirin in the secondary prevention ... dual antiplatelet therapy. Combination antiplatelet regimens with different mechanisms of action to inhibit multiple sites in the thrombotic ...

The Antiplatelet Trialists' Collaboration ... and thus inhibits platelet function by a different mechanism of action than aspirin (see Figure 1). Accordingly, the combination of aspirin and ...

Current guidelines recommend assessment of blood flow (ischemic risk) and bleeding risks when prescribing antiplatelet therapy for patients following PCI. While aspirin is traditionally the ...

Thrombosis is a complication of drug-eluting stent (DES) implantation, and can occur in patients despite optimum antiplatelet therapy with aspirin and clopidogrel. Gori et al. have reported that ...

While aspirin is traditionally the standard antiplatelet agent, recent studies suggest that P2Y12 inhibitors, such as clopidogrel, may be more effective for long-term secondary prevention.